Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Therapy and Autologous PBSCT in Early CLL
NCT00275015Phase 2Completed
- Sponsor
- German CLL Study Group
- Start
- Jan 1998
- Modality
- Orthosteric Ligands, Cytokines & Interferons, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of cyclophosphamide, fludarabine, carmustine, cytarabine, etoposide in chronic lymphocytic leukemia (CLL), sponsored by German CLL Study Group. Started Jan 1998; status: completed.
02
Drugs
cyclophosphamidefludarabinecarmustinecytarabineetoposide
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00275015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00275015.